Penn Mutual Asset Management, LLC Magenta Therapeutics, Inc. Transaction History

Penn Mutual Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$6.07 - $9.89 $55,504 - $90,434	-9,144 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$9.76 - $14.15 $89,245 - $129,387	9,144 New	9,144 $89,000
Q2 2019 Aug 14, 2019	SELL	$13.4 - $17.67 $347,060 - $457,653	-25,900 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$5.7 - $19.7 $147,630 - $510,230	25,900 New	25,900 $26,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.